Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Clinics ; 65(9): 857-863, 2010. graf, tab
Article Dans Anglais | LILACS | ID: lil-562828

Résumé

OBJECTIVES: To evaluate the importance of providing guidelines to patients via active telephone calls for blood pressure control and for preventing the discontinuation of treatment among hypertensive patients. INTRODUCTION: Many reasons exist for non-adherence to medical regimens, and one of the strategies employed to improve treatment compliance is the use of active telephone calls. METHODS: Hypertensive patients (n=354) who could receive telephone calls to remind them of their medical appointments and receive instruction about hypertension were distributed into two groups: a) "uncomplicated" - hypertensive patients with no other concurrent diseases and b) "complicated" - severe hypertensive patients (mean diastolic >110 mmHg with or without medication) or patients with comorbidities. All patients, except those excluded (n=44), were open-block randomized to follow two treatment regimens ("traditional" or "current") and to receive or not receive telephone calls ("phone calls" and "no phone calls" groups, respectively). RESULTS: Significantly fewer patients in the "phone calls" group discontinued treatment compared to those in the "no phone calls" group (4 vs. 30; p<0.0094). There was no difference in the percentage of patients with controlled blood pressure in the "phone calls" group and "no phone calls" group or in the "traditional" and "current" groups. The percentage of patients with controlled blood pressure (<140/90 mmHg) was increased at the end of the treatment (74 percent), reaching 80 percent in the "uncomplicated" group and 67 percent in the "complicated" group (p<0.000001). CONCLUSION: Guidance to patients via active telephone calls is an efficient strategy for preventing the discontinuation of antihypertensive treatment.


Sujets)
Femelle , Humains , Mâle , Adulte d'âge moyen , Antagonistes du récepteur de type 1 de l'angiotensine-II/usage thérapeutique , Antihypertenseurs/usage thérapeutique , Inhibiteurs des canaux calciques/usage thérapeutique , Hydrochlorothiazide/usage thérapeutique , Hypertension artérielle/traitement médicamenteux , Adhésion au traitement médicamenteux/statistiques et données numériques , Aténolol/usage thérapeutique , Protocoles cliniques , Losartan/usage thérapeutique , Téléphone
SÉLECTION CITATIONS
Détails de la recherche